SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai ($BBAI) is trending as investors discuss the company's recent Q3 earnings and acquisition of Ask Sage, a generative AI platform. The community is focused on the potential for government contracts and expansion in the AI defense sector. Some are expressing concerns about revenue decline and potential dilution.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following a mixed reaction to earnings, with a revenue beat offset by lowered guidance due to data center delays, sparking debate about its growth trajectory. The community is weighing the significance of a massive backlog and key partnerships against concerns over profitability and debt. Analyst upgrades are adding fuel to the discussion, with some seeing a buying opportunity in the AI infrastructure play.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors anticipate a decision from the EMA on Blarcamesine, its Alzheimer's drug, with discussions centering on the likelihood of approval and potential market impact. Community chatter highlights the possibility of conditional approval and debates the significance of an upcoming oral explanation to the committee. Some traders express concerns about potential short squeezes while others remain confident in the drug's prospects given its safety profile and long-term data.

Veterans Recognition Currency

Veterans Recognition Currency ($VETERANS) is gaining attention as the community focuses on its chart strength and Phantom availability. The project's mission to support veterans and recent donations are sparking positive sentiment. However, some users are raising concerns and scam allegations about the project, creating a divided discussion.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch ($IMG) is trending as community members highlight its passive Solana ($SOL) rewards system, which distributes $SOL to holders based on volume. The project is preparing to participate in an upcoming Solana hackathon, showcasing its live audit technology. The community emphasizes the project's transparent, community-driven nature and its potential for long-term value accrual through continuous rewards.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto Inc. ($GLTO) is trending due to a massive surge following the acquisition of Damora Therapeutics and a significant funding round, shifting its focus to hematologic malignancies. The community is discussing the potential for a short squeeze given the low float and high cost to borrow, while also noting technical indicators suggesting it may be overbought. Traders are watching for potential multi-day continuation, with some speculating on price targets, while others caution about potential pullbacks.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

DIS is trending as investors anticipate upcoming earnings, with community chatter focusing on streaming performance, theme park attendance, and potential strategic shifts. A recent blackout of Disney-owned channels on YouTube TV amid a contract dispute is also driving conversation, alongside news of a new ESPN sports app and a partnership with DraftKings.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is gaining attention as the community rallies around the revival of OG meme culture and the iconic Rage Guy comics. Discussions center on community building and shared experiences, with members emphasizing unity and resilience. The focus is on establishing a strong cultural movement within the memecoin space, moving beyond fleeting trends.

Biggie is a popular Pitbull across several social media platforms, such as Tiktok, Youtube and Instagram. With a blend of creativity and comedic gestures, Biggie brings animal loving entertainment to millions of viewers through images, videos and reels. With Biggie the Pitbull's growing popularity, the meme coin $BIGGIE was inspired and launched on the ethereum network, leveraging Biggies unique sense of humor and style.

Biggie

Biggie is trending as traders discuss its potential within the meme coin space, drawing comparisons to DOGE and SHIB. Community members highlight the burned liquidity and growing holder base on Phantom, suggesting it's gaining traction. Some are calling for increased attention and trading volume to drive the price higher, emphasizing the potential for significant gains.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending due to anticipation surrounding presentations at the upcoming AASLD Liver Meeting, with the community eagerly awaiting new biomarker data. Discussions revolve around Belapectin's potential, especially in combination with GLP-1 drugs, and speculation about a potential short squeeze is fueled by high short interest.  The potential for a partnership or buyout before year-end is also driving interest, with community members debating potential buyout prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citi Trends, Inc. (NASDAQ: CTRN)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citi Trends, Inc. (NASDAQ: CTRN) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of...

Citi Trends Announces 2024 Holiday Sales Results for Quarter-to-Date Through January 4, 2025

Citi Trends, Inc. (NASDAQ: CTRN), a leading specialty value retailer of apparel, accessories and home trends for way less spend primarily for African American and multicultural families in the United...

Citi Trends to Present at 2025 ICR Conference

SHAREHOLDER ALERT: Purcell and Lefkowitz LLP Announces Shareholder Investigation of Citi Trends, Inc. (NASDAQ: CTRN)

Shares of Citi Trends Inc. ($CTRN ) were up 4% ahead of its third-quarter results, with retail sentiment remaining cautious to bullish with many of its competitors.&nbsp; Wall Street consensus estimates expect the company to post earnings per share of -$0.66 on revenues of $179.1 million. The company has missed estimates thrice out of the last four quarters. Its stock price, meanwhile, has rallied over the past month, reaching a month-high on Monday.&nbsp; In the second quarter, it posted a wider net loss of $18.4 million ($16.2 million adjusted), compared to a net loss of $5.0 million ($4.9 million adjusted) in the same quarter in 2023. Its total sales increased by 1.7%, but comparable store sales declined by 1.7%. That quarter, it also incurred $13.4 million in one-time expenses, including $9.4 million it spent clearing aged inventory. Last month, Citi Trends’ board named Kenneth (Ken) Seipel as CEO from Interim CEO and also appointed Peter Sachse, then executive chairman, as chairman. Announcing its preliminary Q3 2024 results also in November, it said last month its Q3 sales results are expected to be above the company’s previous outlook. Gross margin for Q3 2024 is expected to be 39.8%, an increase of 160 basis points compared to Q3 2023. Q3 2024 adjusted Earnings before Interest, Tax, Depreciation, and Amortization (EBITDA) is expected to be a loss of $3.3 million, which includes strategic costs for in-depth customer and market research and costs to improve operational processes.&nbsp; Citi Trends is a retailer of urban fashion apparel, accessories, and home trends. Its brands include 'Citi Steps' and 'Red Ape,’ and it operates 592 stores across 33 states. <a href="https://stocktwits.com/symbol/CTRN">Citi Trends stock</a> is down 26% year-to-date. &nbsp;For updates and corrections email newsroom[at]stocktwits[dot]com. &nbsp;

Citi Trends operates 592 stores located in 33 states.| Image source: Pexels

Citi Trends Stock Rallies Ahead of Q3 Results

Last month, Citi Trends announced its board named Kenneth (Ken) Seipel as CEO from Interim CEO and also appointed Peter Sachse as chairman.

Equity

Last month, Citi Trends announced its board named Kenneth (Ken) Seipel as CEO from Interim CEO and also appointed Peter Sachse as chairman.


Citi Trends Announces CEO Appointment and Q3 Comparable Store Sales Above Guidance

Citi Trends Inc. (NASDAQ: CTRN) today announced the Board of Directors has appointed Kenneth (Ken) Seipel as Chief Executive Officer, effective November 18, 2024. Mr. Seipel has been serving as the...

Citi Trends Sets Date for Third Quarter 2024 Earnings Release and Conference Call

Citi Trends, Inc. (NASDAQ: CTRN) today announced plans to release its earnings for the third quarter 2024 before the market opens on Tuesday, December 3, 2024. Citi Trends will host a conference call...

Citi Trends Announces Second Quarter Fiscal 2024 Results

Citi Trends Sets Date for Second Quarter 2024 Earnings Release and Conference Call

Citi Trends, Inc. (NASDAQ: CTRN) today announced plans to release its earnings for the second quarter 2024 before the market opens on Tuesday, August 27, 2024. Citi Trends will host a conference call...

Citi Trends Announces 4th Annual Black History Makers Grant Winners

Citi Trends, Inc. engages in the retail of urban fashion apparel, accessories, and home trends. It offers products under its Citi Steps and Red Ape brands. The company was founded in 1946 and is headquartered in Savannah, GA.

Citi Trends Inc

$NVDA

$MSFT

$AAPL

$GOOGL

Which of these Mag 7 stocks are you most bullish on right now?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.79	--	--	N/A
Q2 '25	-$1.01	-$0.82	19.02%	BEAT
Q1 '25	-$0.19	$0.17	187.18%	BEAT
Q4 '24	$0.18	-$1.54	-956.18%	MISSED
Q3 '24	-$0.66	-$0.78	-18.92%	MISSED

CTRN
Citi Trends Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest CTRN News

CTRNCiti Trends Inc